Development and validation of fat-corrected virtual MR elastography to assess fibrosis stage in metabolic dysfunction-associated steatotic liver disease.

objectivesThis study aimed to develop and validate a fat-corrected virtual magnetic resonance elastography (FC-vMRE) framework based on diffusion-weighted imaging (DWI) to assess liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). MATERIALS AND

methodsA total of 463 MASLD patients underwent multi-b-values (0-1500 s/mm²) DWI acquisition, proton density fat fraction (PDFF), and conventional magnetic resonance elastography (MRE). Apparent diffusion coefficient (ADC) parameters were calculated with or without fat correction (based on PDFF). Using the training cohort (n = 361), ADC-to-MRE formulas were derived to compute virtual MRE (vMRE) and FC-vMRE. In the validation cohort (n = 102, with biopsy), the diagnostic performance of vMRE, FC-vMRE, and MRE for fibrosis staging was compared.

resultsADC

conclusionFC-vMRE provides a clinically promising alternative requiring only standard MRI equipment, effectively correcting for fat-related confounding in MASLD, and demonstrating encouraging diagnostic concordance with MRE and histology. This approach shows potential for broader clinical implementation. CRITICAL RELEVANCE STATEMENT: Fat-corrected virtual MRE using diffusion-weighted imaging provides promising fibrosis staging accuracy to conventional magnetic resonance elastography in metabolic dysfunction-associated steatotic liver disease patients without requiring specialized hardware. KEY POINTS: Fat infiltration confounds diffusion measurements in metabolic steatotic liver disease. Fat-corrected virtual MRE showed superior agreement with standard MRE. Hardware-free fibrosis assessment enables accessible liver stiffness measurement.